Simplex Trading »

Monte Rosa Therapeutics shares owned by Simplex Trading

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Simplex Trading

Quarter filed Position value Share count Share price at filing
2025-12-31 $551k 35k 15.68
2025-09-30 $245k 33k 7.40
2025-03-31 $31k 6.8k 4.59
2023-12-31 $56k 10k 5.58
2023-09-30 $125k 26k 4.76

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Invesco Qqq Tr Call Call Option
Tesla Put Put Option
Nvidia Corporation Call Call Option
Tesla Call Call Option
Nvidia Corporation Put Put Option
Ishares Tr Put Put Option
Meta Platforms Call Call Option
Alphabet Call Call Option
Ishares Tr Call Call Option
Spdr Gold Tr Call Call Option
Apple Call Call Option
Alphabet Put Put Option

View all positions for Simplex Trading

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics